Cell cycle actions of parathyroid hormone-related protein in non-small cell lung carcinoma

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 297, Issue 4, 2009, Pages

  Hastings, Randolph H ^a,b,d,e   Montgrain, Philippe R ^a,c,d   Quintana, Rick ^a   Rascon, Yvette ^a   Deftos, Leonard J ^a,c,d   Healy, Erin ^a  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b University of California   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cyclin dependent kinase inhibitor proteins; Extracellular signal regulated mitogen activated protein kinases; G1phase

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ACTIN; BROXURIDINE; CYCLIN A2; CYCLIN B; CYCLIN D1; CYCLIN D2; CYCLIN D3; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1B; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE; PARATHYROID HORMONE RECEPTOR 1; PARATHYROID HORMONE RELATED PROTEIN; PROTEIN P27; PROTEIN TYROSINE KINASE; RETINOBLASTOMA PROTEIN; THYMIDINE;

ARTICLE; CANCER GROWTH; CANCER MODEL; CANCER SURVIVAL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE; CELL CYCLE PROTEINS; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE 2; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LUNG NEOPLASMS; PARATHYROID HORMONE-RELATED PROTEIN; PHOSPHORYLATION; RECEPTOR, PARATHYROID HORMONE, TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 70349972387     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.90560.2008     Document Type: Article

References (35)

1. Abou-Samra AB, Juppner H, Force T, Freeman MW, Kong XF, Schipani E, Urena P, Richards J, Bonventre JV, Potts JJ, et al. Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium. Proc Natl Acad Sci USA 89: 2732-2736, 1992.
2. Brandt DW, Wachsman W, Deftos LJ. Parathyroid hormone-like protein: alternative messenger RNA splicing pathways in human cancer cell lines. Cancer Res 54: 850-853, 1994. (Pubitemid 24068348)
3. Clark JA, Black AR, Leontieva OV, Frey MR, Pysz MA, Kunneva L, Wolszynska-Read A, Roy D, and Black JD. Involvement of the ERK signaling cascased in protein kinase C-mediated cell cycle arrest in intestinal epithelial cells. J Biol Chem 279: 9233-9247, 2004. (Pubitemid 38295987)
4. Datta NS, Chen C, Berry JE, McCauley LK. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest. J Bone Miner Res 20: 1051-1064, 2005. (Pubitemid 40712830)
5. Ditmer LS, Burton DW, Deftos LJ. Elimination of the carboxy-terminal sequences of parathyroid hormone-related protein 1-173 increases production and secretion of the truncated forms. Endocrinology 137: 1608-1617, 1996. (Pubitemid 26133932)
6. Dougherty KM, Blomme EA, Koh AJ, Henderson JE, Pienta KJ, Rosol TJ, McCauley LK. Parathyroid hormone-related protein as a growth regulator of prostate carcinoma. Cancer Res 59: 6015-6022, 1999. (Pubitemid 30004967)
7. Driscoll B, Wu L, Buckley S, Hall FL, Anderson KD, Warburton D. Cyclin D1 antisense RNA destabilizes pRb and retards lung cancer cell growth. Am J Physiol Lung Cell Mol Physiol 273: L941-L949, 1997. (Pubitemid 27508340)
8. Fiaschi-Taesch NM, Takane KK, Masters S, Lopez-Talavera JC, Stewart AF. Parathyroid hormone-related protein as a regulator of pRb and the cell cycle in arterial smooth muscle. Circulation 110: 177-185, 2004. (Pubitemid 38924586)
9. Gujral A, Burton DW, Terkeltaub RA, Deftos LJ. PTHrP induces interleukin 8 production by prostate cancer cells via a novel intracrine mechanism not mediated by its classical nuclear localization sequence. Cancer Res 61: 2282-2288, 2001. (Pubitemid 32692060)
10. Hastings RH, Araiza F, Burton DW, Zhang L, Bedley M, Deftos LJ. Parathyroid hormone-related protein ameliorates death receptor-mediated apoptosis in lung cancer cells. Am J Physiol Cell Physiol 285: C1429-C1436, 2003. (Pubitemid 37429617)
11. Hastings RH, Burton DW, Quintana RA, Biederman E, Gujral A, Deftos LJ. Parathyroid hormone-related protein regulates the growth of orthotopic human lung tumors in athymic mice. Cancer 92: 1402-1410, 2001. (Pubitemid 32947823)
12. Hastings RH, Laux AM, Casillas A, Xu R, Lukas Z, Ernstrom K, Deftos LJ. Sex-specific survival advantage with PTHrP in non-small cell lung carcinoma patients. Clin Cancer Res 12: 499-506, 2006.
13. Hastings RH, Quintana RA, Sandoval R, Burton DW, Deftos LJ. Amino-terminal and mid-molecule parathyroid hormone-related protein, phosphatidylcholine, and type II cell proliferation in silica lung injury. Am J Physiol Lung Cell Mol Physiol 285: L1312-L1322, 2003. (Pubitemid 37448803)
14. Henderson JE, Amizuka N, Warshawsky H, Biasotto D, Lanske BM, Goltzman D, Karaplis AC. Nucleolar localization of parathyroid hormone- related peptide enhances survival of chondrocytes under conditions that promote apoptotic cell death. Mol Cell Biol 15: 4064-4075, 1995.
15. Henderson M, Danks J, Moseley J, Slavin J, Harris T, McKinlay M, Hopper J, Martin T. Parathyroid hormone-related protein production by breast cancers, improved survival, and reduced bone metastases. J Natl Cancer Inst 93: 234-237, 2001. (Pubitemid 32166495)
16. Henderson MA, Danks JA, Slavin JL, Byrnes GB, Choong PF, Hopper JL, Martin TJ. Parathyroid hormone-related protein localization in breast cancers predict improved prognosis. Cancer Res 66: 2250-2256, 2006.
17. Iwamura M, Wu M, Muramoto M, Ohori M, Egawa S, Uchida T, Baba S. Parathyroid hormone-related protein is an independent prognostic factor for renal cell carcinoma. Cancer 86: 1028-1034, 1999. (Pubitemid 29439858)
18. Kalinowski L, Dobrucki LW, Malinski T. Nitric oxide as a second messenger in parathyroid hormone-related protein signaling. J Endocrinol 170: 433-440, 2001. (Pubitemid 32771444)
19. Kemp BE, Moseley JM, Rodda CP, Ebeling PR, Wettenhall RE, Stapleton D, Diefenbach-Jagger H, Ure F, Michelangeli VP, Simmons HA, Raisz LG, Martin TJ. Parathyroid hormone-related protein of malignancy: active synthetic fragments. Science 238: 1568-1570, 1987. (Pubitemid 18032472)
20. Lam MH, Thomas RJ, Martin TJ, Gillespie MT, Jans DA. Nuclear and nucleolar localization of parathyroid hormone-related protein. Immunol Cell Biol 78: 395-402, 2000. (Pubitemid 30655564)
21. Massfelder T, Dann P, Wu TL, Vasavada R, Helwig JJ, Stewart AF. Opposing mitogenic and anti-mitogenic actions of parathyroid hormone-related protein in vascular smooth muscle cells: a critical role for nuclear targeting. Proc Natl Acad Sci USA 94: 13630-13635, 1997. (Pubitemid 28009634)
22. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato JY. D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol 14: 2066-2076, 1994. (Pubitemid 24074604)
23. Mattaj IW, Englmeier L. Nucleocytoplasmic transport: the soluble phase. Annu Rev Biochem 67: 265-306, 1998.
24. Montgrain PR, Quintana RA, Burton DW, Deftos LJ, Casillas A, Rascon YM, Hastings RH. Parathyroid hormone-related protein varies with sex and androgen status in nonsmall cell lung cancer. Cancer 110: 1313-1320, 2007. (Pubitemid 47435604)
25. Nguyen M, He B, Karaplis A. Nuclear forms of parathyroid hormone-related peptide are translated from non-AUG start sites downstream from the initiator methionine. Endocrinology 142: 694-703, 2001. (Pubitemid 32222419)
26. Orloff JJ, Reddy D, de Papp AE, Yang KH, Soifer NE, Stewart AF. Parathyroid hormone-related protein as a prohormone: posttranslational processing and receptor interactions. Endocr Rev 15: 40-60, 1994. (Pubitemid 24058595)
27. Pache JC, Burton DW, Deftos LJ, Hastings RH. A carboxyl leucine-rich region of parathyroid hormone-related protein is critical for nuclear export. Endocrinology 147: 990-998, 2005.
28. Pardo FS, Lien WW, Fox HS, Efird JT, Auilera JA, DW B, Deftos LJ. Parathyroid hormone-related protein expression is correlated with clinical course in patients with glial tumors. Cancer 101: 2622-2628, 2004.
29. Paternot S, Arsenijevic T, Coulonval K, Bockstaele L, Dumont JE, Roger PP. Distinct specificities of pRb phosphorylation by cdk4 activated by cyclin D1 or cyclin D3. Cell Cycle 5: 61-70, 2006.
30. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45, 2001.
31. Rabbani SA, Gladu J, Liu B, Goltzman D. Regulation in vivo of the growth of Leydig cell tumors by antisense ribonucleic acid for parathyroid hormone-related peptide. Endocrinology 136: 5416-5422, 1995.
32. Sanchez I, Dynlacht BD. New insights into cyclins, CDKs, and cell cycle control. Semin Cell Dev Biol 16: 311-321, 2005. (Pubitemid 40504220)
33. Segre G. Receptors for parathyroid hormone and parathyroid hormone-related protein. In: Principles of Bone Biology, edited by Bilezikian JP, Raisz LG, and Rodan GA. New York: Academic, 1996.
34. Shen X, Falzon M. PTH-related protein enhances LoVo colon cancer cell proliferation, adhesion, and integrin expression. Regul Pept 125: 17-27, 2005. (Pubitemid 39593703)
35. Stuart WD, Maeda S, Khera P, Fagin JA, Clemens TL. Parathyroid hormone-related protein induces G1 phase growth arrest of vascular smooth muscle cells. Am J Physiol Endocrinol Metab 279: E60-E67, 2000. (Pubitemid 30609945)